Insider buying · SEC Form 4

CGON insider buying

Open-market purchases of CG Oncology Inc (CGON) stock by its own executives, directors and 10% owners — every Form 4 buy of $250K or more that SPX Lens's daily insider scan has recorded, newest first.

2insider buys on record
$2.67Mbought in total
2different insiders
2by CEOs, CFOs and other chiefs
Nov 19, 2026latest scan with a buy

Every recorded buy

ScanInsiderValueSharesAvg priceTypeFiled
Nov 19, 2026Kuan ArthurCEO$2.37M30,000$78.88AddedNov 18, 2026
Form 4 ↗
Bought $78.88 avg Nov 18; now $80.00 (+1.4%); CEO/CCO cluster buy — CCO Kalofonos also bought $299K same day
Nov 19, 2026Kalofonos IsabelChief Commercial Officer$299K3,751$79.75AddedNov 18, 2026
Form 4 ↗
Bought $79.75 Nov 18; now $80.00 (+0.3%); cluster buy with CEO Kuan Arthur same day

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.